IRX5-related craniofacial dysostosis with osteopenia, intellectual disability, and dental anomalies

Date: 2026-04-16

Scope

Manual curation note for a new disease-level dismech entry covering the IRX5-associated Hamamy syndrome spectrum with emphasis on:

• conservative MONDO grounding
• exact PMID-backed snippets
• a small mechanism graph centered on craniofacial migration and osteogenic mineralization defects
• no unsupported treatment claims

Naming and grounding checks

• Current public MONDO / ClinGen / GenCC anchor:
• MONDO:0012634
• public label: craniofacial dysplasia - osteopenia syndrome
• User-requested framing:
• IRX5-related craniofacial dysostosis with osteopenia, intellectual disability, and dental anomalies
• Curation choice:
• name and disease_term.preferred_term use the more explicit IRX5-related disease phrasing requested by the user and echoed in the recent ClinGen evidence summary.
• disease_term.term.label stays exactly on the current public MONDO label craniofacial dysplasia - osteopenia syndrome.
• Hamamy syndrome is carried as a synonym rather than the primary disease label.

External grounding captured

• ClinGen gene validity:
• IRX5
• HGNC:14361
• disease anchor MONDO:0012634
• mode of inheritance Autosomal recessive
• classification Moderate
• curation id CCID:009212
• Orphanet / GenCC context:
• disease submitted under Orphanet ORPHA:314555
• submitted phrasing includes facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome

Evidence set selected

Core clinical framing

• PMID:17230486
• first syndrome description

• strongest abstract quote for hypertelorism, enamel hypoplasia, osteopenia, fractures, myopia, hearing loss, and borderline intelligence

• PMID:34899143

• fourth reported family
• strongest abstract quote for developmental delay, intellectual disability, dentinogenesis imperfecta, bone fragility, and homozygous IRX5 variant

Molecular disease definition

• PMID:22581230
• discovery paper linking the syndrome to IRX5
• strongest abstract quote for:
  • recessive inheritance
  • homeodomain dysfunction
  • multisystem developmental framing
  • branchial-arch / progenitor migration via SDF1

Experimental mechanism support

• PMID:27453922
• osteoblast-lineage mouse work

• strongest quote for cranial mineralization defects, enlarged sutures, and reduced osteogenic genes

• PMID:32662900

• experimental skeletal biology support showing that Irx3/Irx5 loss causes severe bone deficiency and supports a broader osteogenic role for IRX5

Not central to YAML but useful context

• PMID:30729910
• neuropsychological follow-up in Hamamy syndrome
• supports that cognitive and language/attention phenotypes are measurable and clinically relevant, but not needed once PMID:34899143 is used for the cleaner disease-level intellectual-disability statement

Mechanism graph chosen

1. Biallelic IRX5 homeodomain dysfunction
2. Impaired cranial neural crest and branchial arch progenitor migration
3. Craniofacial developmental defect
4. Impaired osteoblast maturation and cranial mineralization
5. Osteopenia and bone fragility

Rationale:

• PMID:22581230 gives the cleanest proximal molecular lesion and the craniofacial-migration mechanism via SDF1.
• PMID:27453922 and PMID:32662900 give the cleanest skeletal mechanism for osteogenic/mineralization failure.
• I did not add a dedicated mechanistic node for intellectual disability. The human phenotype is real and curated in phenotypes, but the available abstract-level mechanism evidence is still strongest for craniofacial and bone developmental programs rather than a directly demonstrated neural mechanism.

Specific curation choices

• Included phenotype entries for:
• Hypertelorism
• Osteopenia
• Intellectual disability
• Enamel hypoplasia

• High myopia

• Did not add frequency qualifiers. Reason: the published case count is too small and the abstracts do not provide robust quantitative support for frequency bands.

• Did not add treatment entries. Reason: available abstract-level evidence in the selected source set is aimed at syndrome characterization and mechanism, not disease-specific therapeutic efficacy.

• Did not split Hamamy syndrome into a separate root page. Reason: in current curated usage, Hamamy syndrome is the historical syndrome name for this IRX5 disease entity rather than a clearly separable non-IRX5 umbrella.